Advisornet Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Advisornet Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-12,220	Closed	-$33.8K	–	1943
2020 Q2	$34K	Hold	12,220	–	–	﹤0.01%	963
2020 Q1	$29K	Hold	12,220	–	–	﹤0.01%	968
2019 Q4	$57K	Hold	12,220	–	–	﹤0.01%	855
2019 Q3	$41K	Hold	12,220	–	–	﹤0.01%	975
2019 Q2	$40K	Hold	12,220	–	–	﹤0.01%	875
2019 Q1	$37K	Hold	12,220	–	–	﹤0.01%	822
2018 Q4	$33K	Hold	12,220	–	–	﹤0.01%	793
2018 Q3	$41K	Hold	12,220	–	–	0.01%	788
2018 Q2	$32K	Hold	12,220	–	–	﹤0.01%	836
2018 Q1	$27K	Hold	12,220	–	–	﹤0.01%	867
2017 Q4	$24K	Buy	+12,220	New	+$26.6K	﹤0.01%	826

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Advisornet Financial's ATRS Position: Q3 2020 in Review

Advisornet Financial sold out of Antares Pharma, Inc. (ATRS) in Q3 2020, closing a stake of 12,220 shares — an estimated $33.8K sold.

Advisornet Financial first reported a position in ATRS in Q4 2017 and held it in 11 quarters. The position peaked at $57K in Q4 2019. 164 funds tracked by Wall St. Rank hold ATRS as of Q3 2020.

Advisornet Financial reported no remaining Antares Pharma, Inc. position as of Q3 2020 after selling out during the quarter.
Advisornet Financial sold 12,220 Antares Pharma, Inc. shares in Q3 2020, an estimated $33.8K.
Advisornet Financial first reported a position in Antares Pharma, Inc. in Q4 2017 and held it in 11 quarters.
Advisornet Financial's Antares Pharma, Inc. position peaked at $57K in Q4 2019.
164 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2020.

Based on Advisornet Financial's 13F filing for Q3 2020, filed 6 Nov 2020.